Microbiome hypothesis: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (Text replacement - " | pmid" to " | pmid") |
Notjusttired (talk | contribs) m (Text replacement - " | first2" to "| first2") |
||
| Line 19: | Line 19: | ||
<references> | <references> | ||
<ref name="Navaneetharaja, 2016">{{Citation | <ref name="Navaneetharaja, 2016">{{Citation | ||
| last1 = Navaneetharaja | first1 = Navena | authorlink1 = | last2= Griffiths | | last1 = Navaneetharaja | first1 = Navena | authorlink1 = | last2= Griffiths | first2 = Verity | authorlink2 = | last3= Wileman | first3 = Tom | authorlink3 = | last4 = Carding | first4 = Simon R. | authorlink4 = Simon Carding | ||
| title = A Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)? | journal = Journal of Clinical Medicine | volume = 5 | issue = 6 | page = 55 | | title = A Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)? | journal = Journal of Clinical Medicine | volume = 5 | issue = 6 | page = 55 | ||
| date = 2016 | | date = 2016 | ||
| doi = 10.3390/jcm5060055 }}</ref> | | doi = 10.3390/jcm5060055 }}</ref> | ||
<ref name="Newberry, 2018">{{Citation | <ref name="Newberry, 2018">{{Citation | ||
| last1 = Newberry | first1 = F. | authorlink1 = | last2= Hsieh | | last1 = Newberry | first1 = F. | authorlink1 = | last2= Hsieh | first2 = S.-Y. | authorlink2 = | last3= Wileman | first3 = T. | authorlink3 = | last4 = Carding | first4 = S. R. | authorlink4 = Simon Carding | ||
| title = Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome? | journal = Clinical Science | volume = 132 | issue = 5 | page = 523–542 | | title = Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome? | journal = Clinical Science | volume = 132 | issue = 5 | page = 523–542 | ||
| date = 2018 | pmid = | | date = 2018 | pmid = | ||
Revision as of 02:52, October 7, 2022
Theory[edit | edit source]
Evidence[edit | edit source]
- 2015, Support for the Microgenderome: Associations in a Human Clinical Population (see also Sex Differences in CFS Microbiome)
- 2015, Prevotella copri and the microbial pathogenesis of rheumatoid arthritis (March)
- 2016, A Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[1](Full Text)
- 2018, Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome?[2] (Full Text)
- 2018, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression and immunity[3] (Abstract)
See also[edit | edit source]
References[edit | edit source]
- ↑ Newberry, F.; Hsieh, S.-Y.; Wileman, T.; Carding, S. R. (2018), "Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome?", Clinical Science, 132 (5): 523–542, doi:10.1042/CS20171330
- ↑ Proal, Amy; Marshall, Trevor (November 2018). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression and immunity". Frontiers in Pediatrics. doi:10.3389/fped.2018.00373.
